US medical imaging company Imago Systems and Mayo Clinic have signed a know-how license agreement to collaborate on breast imaging with the academic medical center to support clinical trial development and oversee the former’s reader studies for mammography.

The multi-year agreement signed by the parties will focus on clinical trial support for the ICE Reveal product, a visual intelligence software, for breast imaging. The agreement also has a commitment for financial investment from Mayo Clinic in the US medical imaging company.

As per the agreement, one of the breast imaging specialists from Mayo Clinic will head the pilot and pivotal studies of Imago Systems to clinically validate ICE Reveal as applied to screen mammograms.

Imago Systems, Mayo Clinic to advance ICE Reveal for breast imaging. Image courtesy of stockdevil at FreeDigitalPhotos.net.

In the partnership, Mayo Clinic is expected to play an important part in the evolution of the technology to improve breast imaging across various imaging modalities.

The ICE Reveal visual intelligence software involves no additional exposure to radiation and is claimed to be capable of being a safe and effective tool against breast cancer.

Thomas Ramsay – Chairman and CEO of Imago Systems said: “We are very excited about our collaboration with Mayo Clinic, and its support in advancing our imaging technology for better care. Mayo Clinic is a leader in breast cancer detection and treatment, and an advocate for the use of technology to advance healthcare.

“Our technology puts more information into the hands of radiologists and clinicians so that they can make the best possible diagnosis. This agreement with Mayo Clinic will help validate our technology and provide us with a stepping stone for full commercialization.”

Related posts

• Researchers develop new skin patch for melanoma treatment (0)
• V-Wave Interatrial Shunt System gets FDA breakthrough device status for HF (0)
• Boehringer Ingelheim, MD Anderson to advance new cancer treatments (0)
• Finch secures $53m to advance microbiome therapies for CDI, Autism (0)
• US pharma manufacturer Conagen acquires glycoproteins production platform (0)
• Nabriva secures Xenleta FDA approval for community-acquired pneumonia (0)
• Alfasigma USA launches IBS-C drug ZELNORM in US (0)
• TB Alliance bags Pretomanid FDA approval for highly drug-resistant TB (0)
• US gene therapy company Renovacor raises $11m for BAG3 gene therapy (0)
• Landos Biopharma secures $60m in Series B financing round (0)

The post Imago Systems, Mayo Clinic to advance ICE Reveal for breast imaging appeared first on PharmaNewsDaily.com.